Form 8-K - Current report:
SEC Accession No. 0001854270-25-000038
Filing Date
2025-03-20
Accepted
2025-03-20 16:21:03
Documents
15
Period of Report
2025-03-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K snti-20250320.htm   iXBRL 8-K 29920
2 PRESS RELEASE a202503208kex991.htm EX-99 72866
6 image_0.jpg GRAPHIC 26036
  Complete submission text file 0001854270-25-000038.txt   275911

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snti-20250320.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT snti-20250320_lab.xml EX-101.LAB 22530
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snti-20250320_pre.xml EX-101.PRE 13045
18 EXTRACTED XBRL INSTANCE DOCUMENT snti-20250320_htm.xml XML 2835
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 25756739
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)